Address
Email address
Phone number
Website
We manufacture high quality biochemicals, assay kits, antibodies, and recombinant proteins and offer contract services for custom chemical synthesis/analysis, assay development/screening, and drug discovery.
Name
Cayman Europe OÜ
Registry code
11100176
VAT number
EE100948143
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
31.01.2005 (19)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
46901 - Non-specialised wholesale trade
3 478 735 €
321 496 €
9%
3 800 €
(estimate is approximate)
957 816 €
4
Submitted
No tax arrears
34%
31%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Peeter Vahtramäe 22.08.1984 (40) | - | Person competent to receive procedural documents | - | |
Kirk Michael Maxey 05.07.1955 (69) | - | Board member | Right to appoint or recall the majority of the executive management or higher management members | |
Aktsiaselts KEVELT 10418580 | - | - | - | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Maxey Cosmetics OÜ 12668418 | - | Person competent to receive procedural documents | - |
2019 13.04.2020 | 2020 22.03.2021 | 2021 22.03.2022 | 2022 29.03.2023 | 2023 21.03.2024 | |
---|---|---|---|---|---|
Total Revenue | 1 660 893 € | 1 743 213 € | 1 926 752 € | 2 842 003 € | 3 478 735 € |
Net profit (loss) for the period | -19 940 € | 88 605 € | 52 823 € | -225 265 € | 321 496 € |
Profit Margin | -1% | 5% | 3% | -8% | 9% |
Current Assets | 635 371 € | 751 128 € | 913 074 € | 789 539 € | 1 008 676 € |
Fixed Assets | 109 024 € | 88 516 € | 77 259 € | 69 758 € | 40 869 € |
Total Assets | 744 395 € | 839 644 € | 990 333 € | 859 297 € | 1 049 545 € |
Current Liabilities | 24 237 € | 30 881 € | 128 747 € | 222 977 € | 91 729 € |
Non Current Liabilities | - | - | - | - | - |
Total Liabilities | - | - | - | - | - |
Share Capital | - | - | - | - | - |
Equity | 720 158 € | 808 763 € | 861 586 € | 636 320 € | 957 816 € |
Employees | 4 | 4 | 5 | 4 | 4 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | 820 846.21 € | 26 614.45 € | 28 320.4 € | 5 |
2023 Q4 | 796 561.51 € | - | 23 995.27 € | 4 |
2023 Q3 | 1 013 538.69 € | 26 240.94 € | 28 018.99 € | 4 |
2023 Q2 | 867 752.06 € | - | 22 177.35 € | 4 |
2023 Q1 | 825 747.54 € | - | 23 577.36 € | 4 |
2022 Q4 | 632 872.43 € | - | 17 136.42 € | 4 |
2022 Q3 | 720 968.62 € | - | 35 391.08 € | 3 |
2022 Q2 | 800 427.89 € | 21 817.34 € | 23 366.61 € | 4 |
2022 Q1 | 544 604.09 € | - | 21 540.81 € | 4 |
2021 Q4 | 518 084.08 € | - | 19 025.09 € | 4 |
2021 Q3 | 467 092.9 € | 19 246.01 € | 20 865.8 € | 4 |
2021 Q2 | 514 855.74 € | 13 384.41 € | 14 510.88 € | 4 |
2021 Q1 | 428 746.65 € | 13 805.04 € | 14 843.42 € | 3 |
2020 Q4 | 444 433.34 € | - | 12 500.98 € | 3 |
2020 Q3 | 387 584.3 € | 14 236.69 € | 15 294.84 € | 3 |
2020 Q2 | 468 662.12 € | 10 952.79 € | 11 919.6 € | 3 |
2020 Q1 | 558 098.43 € | 13 459.87 € | 14 177.4 € | 3 |